BMY vs JNJ
Bristol Myers Squibb (BMY) and Johnson & Johnson (JNJ) compared side by side. Johnson & Johnson (JNJ) is larger, with a market cap of $635.1B versus $125.6B for Bristol Myers Squibb, about 5.1 times the size. On trailing earnings, BMY is cheaper at 13.5x versus 40.0x for JNJ.
Head to head
| Metric | BMY | JNJ |
|---|---|---|
| Market cap | $125.6B | $635.1B |
| P/E (TTM) | 13.5x | 40.0x |
| Forward P/E | 9.3x | 22.7x |
| Revenue (TTM) | $49.2B | $99.3B |
| Revenue growth | 5.7% | 5.9% |
| Gross margin | 71.7% | 67.8% |
| Operating margin | 34.4% | 25.7% |
| Free cash flow | $11.4B | $22.2B |
| Dividend yield | 4.10% | 2.03% |
| 1-year return | +46.5% | +40.2% |
| 5-year return (annual) | +5.6% | +13.1% |
| Max drawdown | -71% | -51% |
| FI Handbook grade | B | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
BMY vs JNJ FAQ
Which is bigger, BMY or JNJ?
Johnson & Johnson (JNJ) is larger, with a market cap of $635.1B versus $125.6B for Bristol Myers Squibb, about 5.1 times the size.
Is BMY or JNJ cheaper?
On trailing earnings, BMY is cheaper at 13.5x versus 40.0x for JNJ. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, BMY or JNJ?
BMY returned +46.5% over the past year including dividends, versus +40.2% for JNJ, through October 23, 2026.
Which pays a higher dividend, BMY or JNJ?
BMY yields 4.10% versus 2.03% for JNJ.
Full pages: Bristol Myers Squibb · Johnson & Johnson